Richard M. LeLacheur

Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA.

FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.

Part of Charles River Laboratories International, Inc., Primedica Corp develops and produces pharmaceutical products for the biopharmaceutical industry. The company is based in Worcester, MA. Primedica was acquired by Charles River Laboratories, Inc. from rEVO Biologics, Inc. on February 27, 2001 for $42.50 million.

Charles River Laboratories Edinburgh Ltd. provides drug development services. The company is headquartered in Tranent, the United Kingdom.

Pharmanet USA, Inc. provides bioanalytical laboratory services. The company was founded in 1991 and is headquartered in Princeton, NJ.

Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA.

Part of Global Immune Technologies, Inc., Primedical International Ltd. manufactures cardiac monitoring technology and software. The company is based in New Haven, CT. Primedical International was acquired by Global Immune Technologies, Inc. on July 27, 2006 for $20.07 million.

Tandem Labs, Inc. provides bioanalytical chemistry and research services to the pharmaceutical, biopharmaceutical, and biotechnology industries. It offers GLP immunoanalytical, rapid turnaround non-GLP discovery, biotransformation and pharmacodynamics, and method development services. The company was founded in 1981 and is headquartered in Salt Lake City, UT.

Cohesive Technologies, Inc. designs, manufactures, and markets liquid chromatography solutions. It serves to the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company was founded in 1991 and is headquartered in Franklin, MA.

Meadowhawk Biolabs, Inc. is a contract research organization (CRO) that specializes in providing pharmaceutical and biotech clients with drug discovery and development services. The company is based in Marlborough, MA. The company's state-of-the-art facilities and expert scientists offer bioanalytical, pharmacokinetic, and pharmacology studies with fast turn-around times and exacting procedures and protocols. The company partner with clients to delivers results with immediacy and precision. The company was founded by Steve Guyan, Brian Lilley, James Jersey, Jessica Sullivan, Peter Glick, Mary Ann Gallo, Xin Zhang. James Jersey has been the CEO since incorporation.